6. Conclusions
Decision analysis models are a major asset for geriatric oncology. They are particularly adapted for the analysis of multiple variables that cannot be directly addressed by specific clinical trials. Technical developments such as PDAs can make these tools available at bedside for daily practice.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lewis JH, Kilgore ML, Goldman DP, Trimble EL, Kaplan R, Montello MJ, Housman MG, Escarce JJ. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003 Apr 1;21(7):1383–9
Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr. Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999 Dec 30;341(27):2061–7
Kemeny MM, Peterson BL, Kornblith AB, Muss HB, Wheeler J, Levine E, Bartlett N, Fleming G, Cohen HJ. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol. 2003 Jun 15;21(12):2268–75
Extermann M., Balducci L, Lyman GH: What threshold for adjuvant therapy in older breast cancer patients? J Clin Oncol 18:1709–1717, 2000
Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994 Jan 15; 120(2):104–10
Newschaffer CJ, Bush TL, Penberthy LE, Bellantoni M, Helzlsour K, Diener-West M. Does comorbid disease interact with cancer? An epidemiologic analysis of mortality in a cohort of elderly breast cancer patients. J Gerontol A Biol Sci Med Sci. 1998 Sep;53(5):M372–8
Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003 Feb 1;21(3):433–40
Mandelblatt JS, Wheat ME, Monane M, Moshief RD, Hollenberg JP, Tang J. Breast cancer screening for elderly women with and without comorbid conditions. A decision analysis model. Ann Intern Med. 1992 May 1;116(9):722–30
Frasci G, Lorusso V, Panza N, Comella P, Nicolella G, Bianco A, De Cataldis G, Iannelli A, Bilancia D, Belli M, Massidda B, Piantedosi F, Comella G, De Lena M. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced nonsmall-cell lung cancer. J Clin Oncol. 2000 Jul;18(13):2529–36
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of Illness in the Aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 185:94–9, 1963
Lawton MP, Moss M, Fulcomer M, Kleban MH: A research and service oriented multilevel assessment instrument. J Gerontol 37:91–99, 1982
Extermann M, Overcash J, Lyman GH, Parr J, Balducci L: Comorbidity and functional status are independent in older cancer patients. Journal of Clinical Oncology 16:1582–7, 1998
Saliba D, Elliott M, Rubenstein LZ, Solomon DH, Young RT, Kamberg CJ, Roth C, MacLean CH, Shekelle PG, Sloss EM, Wenger NS. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001 Dec;49(12):1691–9
Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, Parodi S, Dal Lago D, Gioia F, Monfardini S, Aapro MS, Serraino D, Zagonel V. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002 Jan 15;20(2):494–502
Zagonel V, Fratino L, Piselli P, Milan I, La Copnca G, Serraino D, Monfardini S. The comprehensive geriatric assessment (CGA) predicts mortality among elderly cancer patients. Proc Am Soc Clin Oncol 21:365a, 2002
Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, Geller BM, Abraham LA, Taplin SH, Dignan M, Cutter G, Ballard-Barbash R. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003 Feb 4;138(3):168–75
Ravdin PM, Siminoff LA, Davis GJ, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 2001 19:980–91
Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol. 2003 Sep 1;21(17):3318–27
Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, Klein J, Helfand M; Cost Work Group of the U.S. Preventive Services Task Force. The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2003 Nov 18;139(10):835–42
Gail MH, Benichou J. Validation studies on a model for breast cancer risk. J Natl Cancer Inst. 1994 Apr 20;86(8):573–5. Erratum in: J Natl Cancer Inst 1994;86(10):803
Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA. 1999 Dec 8;282(22):2156–63
Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med. 2001 Dec 1;111(8):593–601
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science + Business Media, Inc.
About this chapter
Cite this chapter
Extermann, M. (2005). Decision Analysis for Cancer Prevention and Cancer Treatment in the Elderly. In: Balducci, L., Extermann, M. (eds) Biological Basis of Geriatric Oncology. Cancer Treatment and Research, vol 124. Springer, Boston, MA. https://doi.org/10.1007/0-387-23962-6_11
Download citation
DOI: https://doi.org/10.1007/0-387-23962-6_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-23961-3
Online ISBN: 978-0-387-23962-0
eBook Packages: MedicineMedicine (R0)